OBJECTIVE: To present the design of the Bypassing the Blues (BtB) study to examine the impact of a collaborative care strategy for treating depression among patients with cardiac disease. Coronary artery bypass graft (CABG) surgery is one of the most common and costly medical procedures performed in the US. Up to half of post-CABG patients report depressive symptoms, and they are more likely to experience poorer health-related quality of life (HRQoL), worse functional status, continued chest pains, and higher risk of cardiovascular morbidity independent of cardiac status, medical comorbidity, and the extent of bypass surgery. METHODS: BtB was designed to enroll 450 post-CABG patients from eight Pittsburgh-area hospitals including: (1) 300 patients who expressed mood symptoms preceding discharge and at 2 weeks post hospitalization (Patient Health Questionnaire (PHQ-9) >or=10); and (2) 150 patients who served as nondepressed controls (PHQ-9 <5). Depressed patients were randomized to either an 8-month course of nurse-delivered telephone-based collaborative care supervised by a psychiatrist and primary care expert, or to their physicians' "usual care." The primary hypothesis will test whether the intervention can produce an effect size of >or=0.5 improvement in HRQoL at 8 months post CABG, as measured by the SF-36 Mental Component Summary score. Secondary hypotheses will examine the impact of our intervention on mood symptoms, cardiovascular morbidity, employment, health services utilization, and treatment costs. RESULTS: Not applicable. CONCLUSIONS: This effectiveness trial will provide crucial information on the impact of a widely generalizable evidence-based collaborative care strategy for treating depressed patients with cardiac disease.
RCT Entities:
OBJECTIVE: To present the design of the Bypassing the Blues (BtB) study to examine the impact of a collaborative care strategy for treating depression among patients with cardiac disease. Coronary artery bypass graft (CABG) surgery is one of the most common and costly medical procedures performed in the US. Up to half of post-CABG patients report depressive symptoms, and they are more likely to experience poorer health-related quality of life (HRQoL), worse functional status, continued chest pains, and higher risk of cardiovascular morbidity independent of cardiac status, medical comorbidity, and the extent of bypass surgery. METHODS:BtB was designed to enroll 450 post-CABG patients from eight Pittsburgh-area hospitals including: (1) 300 patients who expressed mood symptoms preceding discharge and at 2 weeks post hospitalization (Patient Health Questionnaire (PHQ-9) >or=10); and (2) 150 patients who served as nondepressed controls (PHQ-9 <5). Depressedpatients were randomized to either an 8-month course of nurse-delivered telephone-based collaborative care supervised by a psychiatrist and primary care expert, or to their physicians' "usual care." The primary hypothesis will test whether the intervention can produce an effect size of >or=0.5 improvement in HRQoL at 8 months post CABG, as measured by the SF-36 Mental Component Summary score. Secondary hypotheses will examine the impact of our intervention on mood symptoms, cardiovascular morbidity, employment, health services utilization, and treatment costs. RESULTS: Not applicable. CONCLUSIONS: This effectiveness trial will provide crucial information on the impact of a widely generalizable evidence-based collaborative care strategy for treating depressedpatients with cardiac disease.
Authors: C D Mulrow; J W Williams; E Chiquette; C Aguilar; P Hitchcock-Noel; S Lee; J Cornell; K Stamm Journal: Am J Med Date: 2000-01 Impact factor: 4.965
Authors: B H Mulsant; G S Alexopoulos; C F Reynolds; I R Katz; R Abrams; D Oslin; H C Schulberg Journal: Int J Geriatr Psychiatry Date: 2001-06 Impact factor: 3.485
Authors: Hilary Tindle; Bea Herbeck Belnap; Patricia R Houck; Sati Mazumdar; Michael F Scheier; Karen A Matthews; Fanyin He; Bruce L Rollman Journal: Psychosom Med Date: 2012-01-27 Impact factor: 4.312
Authors: Jordan F Karp; Bruce L Rollman; Charles F Reynolds; Jennifer Q Morse; Frank Lotrich; Sati Mazumdar; Natalia Morone; Debra K Weiner Journal: Pain Med Date: 2012-02-07 Impact factor: 3.750
Authors: Christopher M Celano; Ariana M Albanese; Rachel A Millstein; Carol A Mastromauro; Wei-Jean Chung; Kirsti A Campbell; Sean R Legler; Elyse R Park; Brian C Healy; Linda M Collins; James L Januzzi; Jeff C Huffman Journal: Psychosom Med Date: 2018 Jul/Aug Impact factor: 4.312
Authors: Herbert C Schulberg; Bea Herbeck Belnap; Patricia R Houck; Sati Mazumdar; Charles F Reynolds; Bruce L Rollman Journal: Am J Geriatr Psychiatry Date: 2011-10 Impact factor: 4.105
Authors: Bruce L Rollman; Bea Herbeck Belnap; Sati Mazumdar; Patricia R Houck; Fanyin He; Rene J Alvarez; Herbert C Schulberg; Charles F Reynolds; Dennis M McNamara Journal: J Card Fail Date: 2011-12-22 Impact factor: 5.712
Authors: Mira-Lynn Chavanon; Thomas Meyer; Birgit Herbeck Belnap; Yan Huang; Kaleab Z Abebe; Bruce L Rollman; Christoph Herrmann-Lingen Journal: J Psychosom Res Date: 2019-08-14 Impact factor: 3.006
Authors: Natalia E Morone; Debra K Weiner; Bea Herbeck Belnap; Jordan F Karp; Sati Mazumdar; Patricia R Houck; Fanyin He; Bruce L Rollman Journal: Psychosom Med Date: 2010-06-18 Impact factor: 4.312
Authors: Yael Schenker; Mary Amanda Dew; Charles F Reynolds; Robert M Arnold; Greer A Tiver; Amber E Barnato Journal: Palliat Support Care Date: 2014-02-13